These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36905877)

  • 21. Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.
    Guo LH; Alexopoulos P; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2013 Oct; 263(7):553-60. PubMed ID: 23591828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    Chen M; Xia W
    J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease.
    Wang Q; Antone J; Alsop E; Reiman R; Funk C; Bendl J; Dudley JT; Liang WS; Karr TL; Roussos P; Bennett DA; De Jager PL; Serrano GE; Beach TG; Van Keuren-Jensen K; Mastroeni D; Reiman EM; Readhead BP
    Nat Commun; 2024 Jul; 15(1):5815. PubMed ID: 38987616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer's Disease.
    Hurst C; Pugh DA; Abreha MH; Duong DM; Dammer EB; Bennett DA; Herskowitz JH; Seyfried NT
    Mol Cell Proteomics; 2023 May; 22(5):100542. PubMed ID: 37024090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor improves the cognitive decline of Alzheimer's disease via concurrently inducing the expression of ADAM10 and reducing the expression of β-site APP cleaving enzyme 1 in Tg2576 mice.
    Guo H; Xia D; Liao S; Niu B; Tang J; Hu H; Qian H; Cao B
    Neurosci Res; 2019 May; 142():49-57. PubMed ID: 29702127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.
    Kaipainen A; Korhonen J; Pajusola K; Aprelikova O; Persico MG; Terman BI; Alitalo K
    J Exp Med; 1993 Dec; 178(6):2077-88. PubMed ID: 8245783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of vascular endothelial growth factor levels in CSF and cerebral glucose metabolism across the Alzheimer's disease spectrum.
    Wang Z; Zhou W; Zhou B; Zhang J;
    Neurosci Lett; 2018 Nov; 687():276-279. PubMed ID: 30278247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer's disease.
    Morgan GR; Carlyle BC
    Sci Rep; 2024 Mar; 14(1):7161. PubMed ID: 38531951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease.
    Rayaprolu S; Gao T; Xiao H; Ramesha S; Weinstock LD; Shah J; Duong DM; Dammer EB; Webster JA; Lah JJ; Wood LB; Betarbet R; Levey AI; Seyfried NT; Rangaraju S
    Mol Neurodegener; 2020 May; 15(1):28. PubMed ID: 32381088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
    Provias J; Jeynes B
    Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease.
    Hales CM; Dammer EB; Diner I; Yi H; Seyfried NT; Gearing M; Glass JD; Montine TJ; Levey AI; Lah JJ
    Brain Pathol; 2014 Jul; 24(4):344-51. PubMed ID: 24571648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer's disease.
    Liu X; Chu B; Jin S; Li M; Xu Y; Yang H; Feng Z; Bi J; Wang P
    Int J Neurosci; 2021 Feb; 131(2):154-162. PubMed ID: 32083964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease.
    Eteleeb AM; Novotny BC; Tarraga CS; Sohn C; Dhungel E; Brase L; Nallapu A; Buss J; Farias F; Bergmann K; Bradley J; Norton J; Gentsch J; Wang F; Davis AA; Morris JC; Karch CM; Perrin RJ; Benitez BA; Harari O
    PLoS Biol; 2024 Apr; 22(4):e3002607. PubMed ID: 38687811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
    Barker R; Ashby EL; Wellington D; Barrow VM; Palmer JC; Kehoe PG; Esiri MM; Love S
    Brain; 2014 May; 137(Pt 5):1524-32. PubMed ID: 24618270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
    Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
    Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in App
    Pauls E; Bayod S; Mateo L; Alcalde V; Juan-Blanco T; Sánchez-Soto M; Saido TC; Saito T; Berrenguer-Llergo A; Attolini CS; Gay M; de Oliveira E; Duran-Frigola M; Aloy P
    Genome Med; 2021 Oct; 13(1):168. PubMed ID: 34702310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.
    Alvarez XA; Alvarez I; Aleixandre M; Linares C; Muresanu D; Winter S; Moessler H
    J Alzheimers Dis; 2018; 63(3):1003-1013. PubMed ID: 29710700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer's disease.
    Lin CX; Li HD; Deng C; Liu W; Erhardt S; Wu FX; Zhao XM; Guan Y; Wang J; Wang D; Hu B; Wang J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34953465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.